TLDR
- Shares of Accenture (ACN) fell 4% to a fresh 52-week low near $182 following fiscal 2026 revenue guidance that came in below Street expectations ($71.8B–$73.2B versus $73.9B consensus).
- The consulting giant exceeded Q2 profit forecasts with earnings per share of $2.93 compared to analyst estimates of $2.84, while revenue reached $18.04B, marking a 7.8% year-over-year increase.
- UBS analyst Kevin McVeigh contends investors are overlooking Accenture’s artificial intelligence momentum, noting that AI-linked revenues have surged at a 200% compound annual rate since the 2023 fiscal year.
- The firm increased its fiscal 2026 acquisition budget to $5B from an earlier $3B target, having already spent $1.6B on strategic deals such as Keepler Data Tech, NeuraFlash, Halfspace, and Decho.
- Microsoft (MSFT), another key player in AI discussion, has declined 21% year to date and currently trades at approximately 22x trailing earnings—its most attractive valuation in about ten years.
Shares of Accenture (ACN) began Friday’s session at $186.04 following a 4% decline that pushed the stock to its lowest point in twelve months. The trading range over the past year has stretched from $182.38 to $325.71, with recent weakness stemming from revenue projections that fell short of analyst expectations.
For fiscal year 2026, company leadership projected revenues between $71.8 billion and $73.2 billion. The Street had anticipated approximately $73.9 billion. While the shortfall appears modest, it proved sufficient to send shares tumbling to their annual nadir, overshadowing otherwise strong quarterly performance.
Accenture’s latest quarterly results delivered earnings per share of $2.93, surpassing the $2.84 consensus estimate by nine cents. Quarterly revenues totaled $18.04 billion, representing a 7.8% increase compared to the prior-year period and exceeding the $17.80 billion forecast. The firm maintained a return on equity of 26.33%.
Additionally, the board declared a quarterly cash dividend of $1.63 per share, scheduled for payment on May 15 to shareholders on record as of April 9. Based on current trading levels, this represents an annualized dividend yield of 3.5%.
UBS Sees Undervalued AI Upside
UBS analyst Kevin McVeigh released research highlighting what he characterizes as a market inefficiency in how Accenture’s AI initiatives are being valued. His analysis focused partly on the company’s recent purchase of Keepler Data Tech, a Spanish firm bringing approximately 240 experts specializing in data science, machine learning infrastructure, and cloud engineering.
McVeigh’s core thesis centers on Accenture’s systematic and rapidly expanding AI capabilities being inadequately reflected in the current share price. From the launch of its generative AI programs in fiscal 2023, the company has scaled AI-related revenues to approximately $2.7 billion by fiscal 2025—representing a compound annual expansion rate near 200%. This pace actually exceeds the firm’s early cloud computing growth trajectory, which clocked in around 132% during comparable initial phases.
The consulting powerhouse lifted its fiscal 2026 acquisition spending target from $3 billion to $5 billion. Approximately $1.6 billion has already been allocated across transactions including NeuraFlash, Halfspace, and Decho. McVeigh interprets this deployment as a strategic pivot toward higher-margin, technology-centric services away from traditional labor-dependent consulting models.
Accenture currently employs more than 85,000 AI specialists globally. Contract bookings related to AI and data analytics partnerships are projected to more than double during fiscal 2026.
Institutional Activity Remains Active
Institutional shareholders have maintained active positioning in ACN shares throughout recent reporting periods. Capital International Investors expanded its holdings by 41.1% during Q3, accumulating over 17 million shares with an approximate market value of $4.2 billion. Massachusetts Financial Services increased its stake by 12.8%, now controlling roughly 10.1 million shares.
DDD Partners LLC established a fresh position during Q4, purchasing 9,090 shares valued at around $2.44 million.
Institutional and hedge fund entities collectively control 75.14% of outstanding shares.
Wall Street analyst sentiment leans positive despite near-term caution. Eighteen analysts maintain Buy recommendations on the stock, while ten rate it a Hold. The consensus twelve-month price target sits at $274.88, representing substantial upside from current levels.
Technical indicators show the 50-day moving average at $210.98 and the 200-day moving average at $241.88. Friday’s opening price positioned ACN below both key trend lines.
